In our quest to redefine cancer care, we at GoBroad have embraced a patient-centered philosophy that drives every decision we make. Our unique Multidisciplinary Care (MDC) model was designed not only to treat complex tumors but also to provide an environment where patients feel empowered and understood. We are proud to say that our commitment to excellence has helped us earn recognition as one of the best oncology hospitals in the world.

Innovative Multidisciplinary Care for Complex Cases

At GoBroad, our approach begins with the belief that every patient deserves personalized attention and the most advanced care available. Our patient-driven MDC model brings together experts from various fields—radiology, pathology, medical oncology, surgical oncology, radiation oncology, interventional therapy, and supportive care—to ensure that each treatment plan is as unique as the individual we serve. We work closely with our patients, engaging in thorough discussions and research to understand their conditions and the best nursing measures for even the most challenging cases.

This model is not only about merging expertise but also about integrating conventional therapies with innovative diagnostic and treatment technologies. We have developed a system that streamlines the treatment process, minimizes service redundancies, and shortens the time from diagnosis to treatment initiation. This holistic approach not only boosts recovery chances but also enhances our patients' overall quality of life. Our relentless pursuit of innovation and patient care has consistently placed us among the best oncology hospitals in the world. It is this synergy of cutting-edge technology and compassionate care that sets us apart.

Advanced Technologies Coupled with Uncompromising Safety

In addition to our multidisciplinary approach, we continuously invest in advanced technologies to provide personalized and scientifically cutting-edge treatments. Our collaborations and strategic partnerships—such as our alliance with Beijing University Cancer Hospital established in April 2023—further elevate our capabilities in addressing critical tumor cases. In September, we launched several innovative PRRT treatment projects for neuroendocrine tumors, and by November, we had secured the Lutetium-177 nuclear application qualification. These milestones have not only enhanced our technical expertise but have also reinforced our reputation as one of the best oncology hospitals in the world.

Safety and efficiency are at the heart of our operations. At our state-of-the-art facility, we have implemented rigorous radiation shielding measures and conducted professional radiation safety analyses to ensure that our specialized Lutetium-177 treatment rooms comply with all safety standards. With four dedicated radionuclide therapy wards, we are capable of treating approximately 200 patients annually, ensuring that our advanced therapies are delivered in a secure and controlled environment. This steadfast commitment to patient safety and quality care is a key factor in why we are regarded among the best oncology hospitals in the world.

Conclusion

Our journey at GoBroad is defined by innovation, compassion, and an unwavering commitment to transforming cancer care. Through our patient-driven MDC model and the integration of groundbreaking technologies, we offer treatments that not only target the disease but also improve overall well-being. Every step we take is motivated by the goal of providing our patients with the best possible outcomes, making us proud to be recognized as one of the best oncology hospitals in the world. We remain dedicated to evolving and pushing the boundaries of what modern oncology care can achieve.